問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
莊建淮
下載
2025-12-15 - 2028-06-29
Condition/Disease
Test Drug
Participate Sites3Sites
Recruiting3Sites
2021-03-01 - 2026-12-30
Participate Sites6Sites
Not yet recruiting3Sites
2024-06-30 - 2029-06-30
Participate Sites8Sites
Recruiting8Sites
2022-11-18 - 2027-12-31
Participate Sites7Sites
Not yet recruiting2Sites
Recruiting5Sites
2024-12-01 - 2031-05-31
Recruiting6Sites
2022-07-06 - 2025-05-31
Not yet recruiting5Sites
Recruiting1Sites
2024-09-02 - 2027-12-31
2024-01-01 - 2030-11-30
Hepatocellular Carcinoma
Livmoniplimab (ABBV-151)；Budigalimab (ABBV-181)
Participate Sites5Sites
全部
